Skip NavigationSkip to Content

Spontaneous Control of HCV Is Associated With Expression of HLA-B*57 and Preservation of Targeted Epitopes

  1. Author:
    Kim, A. Y.
    Kuntzen, T.
    Timm, J.
    Nolan, B. E.
    Baca, M. A.
    Reyor, L. L.
    Berical, A. C.
    Feller, A. J.
    Johnson, K. L.
    Zur Wiesch, J. S.
    Robbins, G. K.
    Chung, R. T.
    Walker, B. D.
    Carrington, M.
    Allen, T. M.
    Lauer, G. M.
  2. Author Address

    [Kim, Arthur Y.; Reyor, Laura L.; Johnson, Kristin L.; Robbins, Gregory K.; Walker, Bruce D.; Allen, Todd M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA 02114 USA. [Nolan, Brian E.; Reyor, Laura L.; Chung, Raymond T.; Lauer, Georg M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA. [Kim, Arthur Y.; Kuntzen, Thomas; Baca, Melanie A.; Berical, Andrew C.; Feller, Andrea J.; Walker, Bruce D.; Carrington, Mary; Allen, Todd M.] Ragon Inst MGH Massachusetts Inst Technol & Harva, Boston, MA USA. [Timm, Joerg] Univ Essen Gesamthsch, Inst Virol, Essen, Germany. [Zur Wiesch, Julian Schulze] Univ Med Ctr Hamburg Eppendorf, Div Med, Hamburg, Germany. [Zur Wiesch, Julian Schulze; Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA. [Carrington, Mary] NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21701 USA.;Kim, AY, Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, GRB-504, Boston, MA 02114 USA.;akim1@partners.org
    1. Year: 2011
    2. Date: Feb
  1. Journal: Gastroenterology
    1. 140
    2. 2
    3. Pages: 686-U434
  2. Type of Article: Article
  3. ISSN: 0016-5085
  1. Abstract:

    BACKGROUND & AIMS: HLA class I alleles are linked to spontaneous control of hepatitis C virus (HCV) and human immunodeficiency virus-1, but for HCV the roles of particular alleles and corresponding CD8(+) T-cell responses remain incompletely defined. We aimed to determine the correlations between these alleles and natural outcomes of HCV and determine associated key T-cell responses. METHODS: In a cohort of HCV individuals, we determined HLA class I alleles, HCV outcomes, T-cell responses, and examined sequence data for mutational changes within key epitopes. RESULTS: Carriage of HLA-B*57 was associated with a higher rate of viral clearance (risk ratio = 2.0; 95% confidence interval: 1.2-3.4), while HLA-B*08 was associated with a lower rate (risk ratio = 0.34; 95% confidence interval: 0.1-0.9]. Two HLA-B*57-restricted T-cell epitopes were targeted in spontaneous clearance; subjects with chronic viremia expressing HLA-B*57 harbored HCV strains with a high frequency of mutations in key residues. HLAB*57-mediated escape was supported by diminished immune recognition of these variants and acute HCV infection revealing viral evolution toward less recognized variants. Analysis of a genotype 1b strain from a single-source HCV outbreak in which HLA-B*57 was not protective revealed sequence variations that interfere with immunogenicity, thereby preventing HLA-B*57-mediated immune pressure. CONCLUSIONS: Our data indicate a role of HLA-B*57-restricted CD8(+) T-cell responses in mediating spontaneous clearance and evolution in HCV infection, and viral strains containing epitope variants that are less recognized abrogate the protective effects of HLA-B*57. The finding that HLAB*57-mediated antiviral immunity is associated with control of both human immunodeficiency virus-1 and HCV suggests a common shared mechanism of a successful immune response against persistent viruses.

    See More

External Sources

  1. DOI: 10.1053/j.gastro.2010.09.042
  2. WOS: 000286593600047

Library Notes

  1. Fiscal Year: FY2010-2011
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel